Carbapenem-Resistant Organisms Isolated in Surgical Site Infections in Benin: A Public Health Problem

• Published in: Tropical Medicine and Infectious Disease
• Main Authors: Carine Laurence Yehouenou, Reza Soleimani, Arsène A. Kpangon, Anne Simon, Francis M. Dossou, Olivia Dalleur
• Format: Article
• Language: English
• Published: MDPI AG 2022-08-01
• Subjects: carbapenem-resistant organisms; OXA-48; NDM; VIM; surgical site infections; Benin
• Online Access: https://www.mdpi.com/2414-6366/7/8/200

An alarming worldwide increase in antimicrobial resistance is complicating the management of surgical site infections (SSIs), especially in low-middle income countries. The main objective of this study was to describe the pattern of carbapenem-resistant bacteria in hospitalized patients and to highlight the challenge of their detection in Benin. We collected pus samples from patients suspected to have SSIs in hospitals. After bacterial identification by MALDI-TOF mass spectrometry, antimicrobial susceptibility was performed according to the Kirby–Bauer method. Carbapenem-resistant strains were characterized using, successively, the Modified Hodge Test (MHT), the RESIST-5 O.K.N.V.I: a multiplex lateral flow and finally the polymerase chain reaction. Six isolates were resistant to three tested carbapenems and almost all antibiotics we tested but remained susceptible to amikacin. Four (66.7%) of them harbored some ESBL genes (bla_CTX-M-1 and bla_TEM-1). The MHT was positive for <i>Carbapenems</i> but not for <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii.</i> As surgical antimicrobial prophylaxis, five of the six patients received ceftriaxone. The following carbapenems genes were identified: bla _OXA-48(33.3%, <i>n</i> = 2), bla_NDM (33.3%, <i>n</i> = 2) and bla_VIM (33.3%, <i>n</i> = 2). These findings indicate a need for local and national antimicrobial resistance surveillance and the strengthening of antimicrobial stewardship programs in the country.